Efficacy and safety of cannabidiol in a single-center pediatric drug-resistant epilepsy cohort: a retrospective study
CBD demonstrated a good safety and tolerability profile and appeared to be a promising therapeutic option for the management of DRE. It offers a valuable alternative for seizure control and has a positive impact on social interaction, with overall improvement in the quality of life for patients and their caregivers.
Authors
- C. Sferro
- Gabriella Di Rosa (ORCID: https://orcid.org/0000-0003-3061-3249)
- Ambra Butera (ORCID: https://orcid.org/0009-0008-3925-1292)
- Giulia Spoto
- Antonio Gennaro Nicotera (ORCID: https://orcid.org/0000-0002-0847-2243)
- Carla Consoli
- Maria Giovanna Grella (ORCID: https://orcid.org/0000-0002-3868-7093)
- Graziana Ceraolo
- Ivana Giunta
- Maria Spanò (ORCID: https://orcid.org/0000-0003-4986-6289)
- Maria Ludovica Albertini
Institutions
- University of Messina (IT)
- Istituto Ortopedico Gaetano Pini (IT)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-07-16
- DOI
- https://doi.org/10.3389/fneur.2025.1616480
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00